Literature DB >> 8423881

Borrelia burgdorferi-specific intrathecal antibody production in neuroborreliosis: a follow-up study.

S Hammers-Berggren1, K Hansen, A M Lebech, M Karlsson.   

Abstract

We used a capture ELISA with biotinylated Borrelia burgdorferi flagella as antigen to analyze the kinetics of intrathecal antibody production against B burgdorferi in 27 patients with neuroborreliosis. All patients had lymphocytic pleocytosis, 13/27 had intrathecal specific IgM production, and 26/27 had intrathecal IgG synthesis against B burgdorferi before therapy. All patients improved after antibiotic treatment. At follow-up, 11 months to 8 years later (median, 1 1/2 years), 20 patients had had a complete clinical recovery, and seven suffered from sequelae. One patient without sequelae had persistent specific intrathecal IgM synthesis. Ten of 20 patients without sequelae and five of seven patients with sequelae had persistent intrathecal IgG production against B burgdorferi. None of the 16 patients with persistent specific intrathecal antibody synthesis had pleocytosis at follow-up. Therefore, intrathecal immunoglobulin production against B burgdorferi, especially IgG, may persist for years after treatment of neuroborreliosis without clinical signs of active disease.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8423881     DOI: 10.1212/wnl.43.1_part_1.169

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  40 in total

1.  Humoral immune responses in patients with Lyme neuroborreliosis.

Authors:  Tjasa Cerar; Katarina Ogrinc; Franc Strle; Eva Ruzić-Sabljić
Journal:  Clin Vaccine Immunol       Date:  2010-02-17

Review 2.  Lyme Neuroborreliosis: Clinical Outcomes, Controversy, Pathogenesis, and Polymicrobial Infections.

Authors:  Juan Carlos Garcia-Monco; Jorge L Benach
Journal:  Ann Neurol       Date:  2019-01       Impact factor: 10.422

Review 3.  Laboratory diagnosis of Lyme disease: advances and challenges.

Authors:  Adriana R Marques
Journal:  Infect Dis Clin North Am       Date:  2015-06       Impact factor: 5.982

Review 4.  [Neuroborreliosis - Diagnostics, treatment and course].

Authors:  R Dersch; S Rauer
Journal:  Nervenarzt       Date:  2017-04       Impact factor: 1.214

5.  Lyme borreliosis--an overdiagnosed disease?

Authors:  B Svenungsson; G Lindh
Journal:  Infection       Date:  1997 May-Jun       Impact factor: 3.553

6.  Neurologic manifestations of lyme disease.

Authors:  John J Halperin
Journal:  Curr Infect Dis Rep       Date:  2011-08       Impact factor: 3.725

7.  [Clinical courses of acute and chronic neuroborreliosis following treatment with ceftriaxone].

Authors:  R Kaiser
Journal:  Nervenarzt       Date:  2004-06       Impact factor: 1.214

8.  Prevalence of taste disorders in idiopathic and B. burgdorferi-associated facial palsy.

Authors:  Andreas Hufschmidt; V Shabarin; O Yakovlev-Leyendecker; O Deppe; S Rauer
Journal:  J Neurol       Date:  2009-07-15       Impact factor: 4.849

9.  CSF B--lymphocyte chemoattractant (CXCL13) in the early diagnosis of acute Lyme neuroborreliosis.

Authors:  Unn Ljøstad; Ase Mygland
Journal:  J Neurol       Date:  2008-03-17       Impact factor: 4.849

10.  Variable CSF findings in early and late Lyme neuroborreliosis: a follow-up study in 47 patients.

Authors:  R Kaiser
Journal:  J Neurol       Date:  1994-12       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.